ORG Wealth Partners LLC Purchases 17,488 Shares of Kenvue Inc. (NYSE:KVUE)

ORG Wealth Partners LLC lifted its stake in Kenvue Inc. (NYSE:KVUE) by 2,169.7% in the first quarter, HoldingsChannel.com reports. The firm owned 18,294 shares of the company’s stock after purchasing an additional 17,488 shares during the quarter. ORG Wealth Partners LLC’s holdings in Kenvue were worth $437,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also modified their holdings of KVUE. Fulton Bank N.A. lifted its position in Kenvue by 0.6% during the 1st quarter. Fulton Bank N.A. now owns 78,888 shares of the company’s stock worth $1,892,000 after buying an additional 465 shares in the last quarter. Deseret Mutual Benefit Administrators lifted its position in Kenvue by 29.0% during the 4th quarter. Deseret Mutual Benefit Administrators now owns 2,528 shares of the company’s stock worth $54,000 after buying an additional 568 shares in the last quarter. SRS Capital Advisors Inc. lifted its position in Kenvue by 67.4% during the 4th quarter. SRS Capital Advisors Inc. now owns 1,418 shares of the company’s stock worth $30,000 after buying an additional 571 shares in the last quarter. Keystone Financial Group lifted its position in Kenvue by 4.8% during the 4th quarter. Keystone Financial Group now owns 12,736 shares of the company’s stock worth $272,000 after buying an additional 578 shares in the last quarter. Finally, First Horizon Advisors Inc. lifted its position in Kenvue by 2.4% during the 4th quarter. First Horizon Advisors Inc. now owns 25,047 shares of the company’s stock worth $535,000 after buying an additional 580 shares in the last quarter. Institutional investors and hedge funds own 97.64% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have recently commented on KVUE shares. Redburn Atlantic started coverage on shares of Kenvue in a report on Thursday, April 10th. They set a “neutral” rating and a $23.50 target price on the stock. Barclays raised their target price on shares of Kenvue from $22.00 to $23.00 and gave the stock an “equal weight” rating in a report on Monday, May 12th. Citigroup reaffirmed a “neutral” rating on shares of Kenvue in a report on Friday, June 13th. Evercore ISI began coverage on shares of Kenvue in a report on Monday, March 24th. They set an “in-line” rating and a $25.00 target price on the stock. Finally, UBS Group lifted their price objective on shares of Kenvue from $24.00 to $25.00 and gave the company a “neutral” rating in a research note on Friday, May 9th. Seven research analysts have rated the stock with a hold rating and five have given a buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $25.33.

Kenvue Stock Performance

NYSE KVUE opened at $21.35 on Thursday. The firm’s fifty day moving average price is $23.02 and its two-hundred day moving average price is $22.46. The stock has a market cap of $40.95 billion, a PE ratio of 38.81, a PEG ratio of 3.33 and a beta of 0.98. Kenvue Inc. has a fifty-two week low of $17.67 and a fifty-two week high of $25.17. The company has a debt-to-equity ratio of 0.63, a quick ratio of 0.60 and a current ratio of 0.86.

Kenvue (NYSE:KVUE) last posted its earnings results on Thursday, May 8th. The company reported $0.24 earnings per share for the quarter, topping analysts’ consensus estimates of $0.23 by $0.01. The firm had revenue of $3.74 billion for the quarter, compared to analysts’ expectations of $3.69 billion. Kenvue had a net margin of 6.90% and a return on equity of 20.87%. The company’s revenue was down 3.9% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.28 earnings per share. On average, equities analysts expect that Kenvue Inc. will post 1.14 EPS for the current fiscal year.

Kenvue Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Wednesday, May 28th. Stockholders of record on Wednesday, May 14th were issued a dividend of $0.205 per share. The ex-dividend date was Wednesday, May 14th. This represents a $0.82 dividend on an annualized basis and a dividend yield of 3.84%. Kenvue’s dividend payout ratio (DPR) is presently 149.09%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.